These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17549667)

  • 1. Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.
    Westerman BA; Breuer RH; Poutsma A; Chhatta A; Noorduyn LA; Koolen MG; Postmus PE; Blankenstein MA; Oudejans CB
    Int J Biol Markers; 2007; 22(2):114-23. PubMed ID: 17549667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
    Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
    Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
    Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
    La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
    Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.
    Kim G; Kim M; Nam EJ; Lee JY; Park E
    Am J Surg Pathol; 2024 Mar; 48(3):364-372. PubMed ID: 37981832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
    Miki M; Ball DW; Linnoila RI
    Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.
    Truong N; Chun SM; Kim TI; Suh YA; Jang SJ
    Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
    Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
    Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
    Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
    Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
    Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
    Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
    Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
    Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
    Chen H; Thiagalingam A; Chopra H; Borges MW; Feder JN; Nelkin BD; Baylin SB; Ball DW
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5355-60. PubMed ID: 9144241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
    Jiang T; Collins BJ; Jin N; Watkins DN; Brock MV; Matsui W; Nelkin BD; Ball DW
    Cancer Res; 2009 Feb; 69(3):845-54. PubMed ID: 19176379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.
    Leonard JH; Cook AL; Van Gele M; Boyle GM; Inglis KJ; Speleman F; Sturm RA
    Int J Cancer; 2002 Sep; 101(2):103-10. PubMed ID: 12209986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atonal homolog 1 is a tumor suppressor gene.
    Bossuyt W; Kazanjian A; De Geest N; Van Kelst S; De Hertogh G; Geboes K; Boivin GP; Luciani J; Fuks F; Chuah M; VandenDriessche T; Marynen P; Cools J; Shroyer NF; Hassan BA
    PLoS Biol; 2009 Feb; 7(2):e39. PubMed ID: 19243219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.
    Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T
    Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
    Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
    Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.